It looks like it to me: If I'm interpreting the above correctly,...

It looks like it to me:



If I'm interpreting the above correctly, there could also be another expense which was paid to OVIK Health ($1.75M - $1.2M = $0.55M?).

Yep, too much guesswork so I've changed my approach:

CFO, David said something along the lines of "Cash burn is expected to decrease (from $12.3M in Q423) over the next ~6 quarters to profitability" during the February investor briefing which implies that they're managing the expenses well given the substantial investments into future growth. I think that's all we really need to know (otherwise we'll go crazy/crazier trying to guess the rest).

So, let's say the cash burn/net loss (for this exercise I'll assume they're equal which could be incorrect) for Q1 slightly decreases to $12.2M. EPS should be ($12.2M)/25.5M = (0.48) which would be ~13% miss which I don't have an issue with given the expectations for the second half of 2024 and beyond.

Hopefully, I haven't misinterpreted the commentary guidance and miscalculated again

P.S. thanks for the questions. Without the nudge, I probably would've let this quarter's EPS guesstimate slide but I feel more comfortable now that I've got a better expectation (at least in my head).

Interestingly, revenue consensus for Q2 is currently at $18.4M.



Although I'm sure we'd all be very happy with that, I'd be happy with anything over $17.5M before the ramp up during Q3 and Q4 to achieve $78.5 –$84.5 million for FY24 (possibly higher if all goes well as indicated by management).

Preliminary highlights in April, if released, could provide the additional insight that we seek.